Multidisciplinary care and management selection in prostate cancer

Seminars in Radiation Oncology

Volumn 23, Issue 3, 2013, Pages 157-164

  Aizer, Ayal A ^a   Paly, Jonathan J ^b   Efstathiou, Jason A ^b  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ANDROGEN DEPRIVATION THERAPY; BRACHYTHERAPY; CANCER RISK; CRYOTHERAPY; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MULTIMODALITY CANCER THERAPY; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIOFREQUENCY ABLATION; REIMBURSEMENT; REVIEW; SOCIAL CLASS; TRANSLATIONAL RESEARCH;

CANCER CARE FACILITIES; HUMANS; MALE; PATIENT CARE MANAGEMENT; PATIENT CARE TEAM; PATIENT SATISFACTION; PROSTATIC NEOPLASMS; REFERRAL AND CONSULTATION;

EID: 84878845001     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2013.01.001     Document Type: Review

References (53)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29.
2. Siegel R., Ward E., Brawley O., et al. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 61:212-236.
3. NCCN Clinical Practice Guidelines in Oncology. Prostate Cancer Accessed November 26, 2011. http://www.nccn.org.
4. Tosoian J.J., Trock B.J., Landis P., et al. Active surveillance program for prostate cancer: An update of the Johns Hopkins experience. J Clin Oncol 2011, 29:2185-2190.
5. Klotz L., Zhang L., Lam A., et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010, 28:126-131.
6. Van den Bergh R.C., Roemeling S., Roobol M.J., et al. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur Urol 2009, 55:1-8.
7. Bill-Axelson A., Holmberg L., Ruutu M., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011, 364:1708-1717.
8. Wilt T.J., Brawer M.K., Jones K.M., et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012, 367:203-213.
9. Widmark A: Prospective randomized trial comparing external beam radiotherapy versus watchful waiting in early prostate cancer. Annual Meeting of the American Society of Radiation Oncology, Miami, FL, Abstract, 2011.
10. Paulson D.F., Lin G.H., Hinshaw W., et al. Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol 1982, 128:502-504.
11. Hanks G.E. More on the Uro-Oncology Research Group report of radical surgery vs. radiotherapy for adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1988, 14:1053-1054.
12. Byhardt R.W., Greenlaw R.H., Jensen R., et al. Re: Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol 1983, 130:1205-1206.
13. Zelefsky M.J., Levin E.J., Hunt M., et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:1124-1129.
14. D'Amico A.V., Manola J., Loffredo M., et al. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: A randomized controlled trial. JAMA 2004, 292:821-827.
15. Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 1997, 337:295-300.
16. Zietman A.L., Bae K., Slater J.D., et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from proton radiation oncology group/American College of Radiology 95-09. J Clin Oncol 2010, 28:1106-1111.
17. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:67-74.
18. Kane C.J. Robotic prostatectomy improves outcomes-After the potentially risky adoption phase. Oncology (Williston Park) 2012, 26:630. 626, 628.
19. Gillitzer R., Thüroff J.W. Technical advances in radical retropubic prostatectomy techniques for avoiding complications. part II: Vesico-urethral anastomosis and nerve-sparing prostatectomy. BJU Int 2003, 92:178-184.
20. Sanda M.G., Dunn R.L., Michalski J., et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008, 358:1250-1261.
21. Resnick M.J., Koyama T., Fan K.H., et al. Long-term functional outcomes after treatment for localized prostate cancer. N Eng J Med 2013, 368:425-536.
22. Gray PJ, Paly JJ, Yeap BY: Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer. Cancer Feb 22. [Epub ahead of print]. doi:10.1002/cncr.27956.
23. Hayes J.H., Ollendorf D.A., Pearson S.D., et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: A decision analysis. JAMA 2010, 304:2373-2380.
24. Kasperzyk J.L., Shappley W.V., Kenfield S.A., et al. Watchful waiting and quality of life among prostate cancer survivors in the physicians' health study. J Urol 2011, 186:1862-1867.
25. Ward J.F., Jones J.S. Focal cryotherapy for localized prostate cancer: A report from the national Cryo on-line database (COLD) registry. BJU Int 2012, 109:1648-1654.
26. Pfeiffer D., Berger J., Gross A.J. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes. BJU Int 2012, 110:1702-1707.
27. Colin P., Mordon S., Nevoux P., et al. Focal laser ablation of prostate cancer: Definition, needs, and future. Adv Urol 2012, 2012:589160.
28. Sheets N.C., Goldin G.H., Meyer A.M., et al. Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA 2012, 307:1611-1620.
29. Spratt D.E., Pei X., Yamada J., et al. Long-term survival and toxicity in patients treated with high-dose intensity modulated Radiation therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2013, 85:686-692.
30. McBride S.M., Wong D.S., Dombrowski J.J., et al. Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: Preliminary results of a multi-institutional phase 1 feasibility trial. Cancer 2012, 118:3681-3690.
31. Arcangeli S., Strigari L., Gomellini S., et al. Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2012, 84:1172-1178.
32. Wilbert J., Baier K., Hermann C., et al. Accuracy of real-time couch tracking during 3-dimensional conformal Radiation therapy, intensity modulated radiation therapy, and volumetric modulated arc therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2013, 85:237-242.
33. Mitchell J.M., Sunshine J.H. Consequences of physicians' ownership of health care facilities-Joint ventures in radiation therapy. N Engl J Med 1992, 327:1497-1501.
34. Falit B.P., Gross C.P., Roberts K.B. Integrated prostate cancer centers and over-utilization of IMRT: A close look at fee-for-service medicine in radiation oncology. Int J Radiat Oncol Biol Phys 2010, 76:1285-1288.
35. Moore M.J., O'Sullivan B., Tannock I.F. How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 1988, 6:1736-1745.
36. Fowler F.J., McNaughton Collins M., Albertsen P.C., et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000, 283:3217-3222.
37. Aizer A.A., Paly J.J., Zietman A.L., et al. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. J Clin Oncol 2012, 30:3071-3076.
38. Bellardita L., Donegani S., Spatuzzi A.L., et al. Multidisciplinary versus one-on-one setting: A qualitative study of clinicians' perceptions of their relationship with patients with prostate cancer. J Oncol Pract 2011, 7:e1-e5.
39. Gomella L.G., Lin J., Hoffman-Censits J., et al. Enhancing prostate cancer care through the multidisciplinary clinic approach: A 15-year experience. J Oncol Pract 2010, 6:e5-e10.
40. Gardner T.B., Barth R.J., Zaki B.I., et al. Effect of initiating a multidisciplinary care clinic on access and time to treatment in patients with pancreatic adenocarcinoma. J Oncol Pract 2010, 6:288-292.
41. Vinod S.K., Sidhom M.A., Delaney G.P. Do multidisciplinary meetings follow guideline-based care?. J Oncol Pract 2010, 6:276-281.
42. Litton G., Kane D., Clay G., et al. Multidisciplinary cancer care with a patient and physician satisfaction focus. J Oncol Pract 2010, 6:e35-e37.
43. Hudak J.L., McLeod D.G., Brassell S.A., et al. The design and implementation of a multidisciplinary prostate cancer clinic. Urol Nurs 2007, 27:491-498.
44. Valicenti R.K., Gomella L.G., El-Gabry E.A., et al. The multidisciplinary clinic approach to prostate cancer counseling and treatment. Semin Urol Oncol 2000, 18:188-191.
45. Brassell S.A., Dobi A., Petrovics G., et al. The Center for Prostate Disease Research (CPDR): A multidisciplinary approach to translational research. Urol Oncol 2009, 27:562-569.
46. Stewart S.B., Bañez L.L., Robertson C.N., et al. Utilization trends at a multidisciplinary prostate cancer clinic: Initial 5-year experience from the duke Prostate Center. J Urol 2012, 187:103-108.
47. Magnani T., Valdagni R., Salvioni R., et al. The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: Incidence of management changes. BJU Int 2012, 110:998-1003.
48. Korman H, Lanni T Jr, Shah C, et al: Impact of a prostate multidisciplinary clinic program on patient treatment decisions and on adherence to NCCN guidelines: The William Beaumont Hospital experience. Am J Clin Oncol (in press).
49. Basler J.W., Jenkins C., Swanson G. Multidisciplinary management of prostate malignancy. Curr Urol Rep 2005, 6:228-234.
50. Aizer AA, Paly JJ, Zietman AL, et al: Multidisciplinary care and management of very low-risk prostate cancer. American Society of Clinical Oncology - Genitourinary Cancers Symposium, Abstract, Orlando, FL, 2013.
51. Eldefrawy A., Katkoori D., Abramowitz M., et al. Active surveillance vs. treatment for low-risk prostate cancer: A cost comparison. Urol Oncol 2011.
52. Corcoran A.T., Peele P.B., Benoit R.M. Cost comparison between watchful waiting with active surveillance and active treatment of clinically localized prostate cancer. Urology 2010, 76:703-707.
53. Stephenson A.J., Bolla M., Briganti A., et al. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. Eur Urol 2012, 61:443-451.